Development of a subcutaneous formulation for trastuzumab - nonclinical and clinical bridging approach to the approved intravenous dosing regimen (Q38037466)

From Wikidata
Jump to navigation Jump to search
scientific article published on 23 August 2012
edit
Language Label Description Also known as
English
Development of a subcutaneous formulation for trastuzumab - nonclinical and clinical bridging approach to the approved intravenous dosing regimen
scientific article published on 23 August 2012

    Statements

    Development of a subcutaneous formulation for trastuzumab - nonclinical and clinical bridging approach to the approved intravenous dosing regimen (English)
    23 August 2012
    401-409

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit